
UBS ETF MSCI UK Shs -A- Distribution
UBS ETF MSCI UK Shs -A- Distribution (GB:UC63) Price & Chart
GB:UC63 ETF Chart & Stats
- Day’s Range
- GBP 2,671.00 - GBP 2,671.00
- 52-Week Range
- GBP 2,430.80 - GBP 2,824.62
- Previous Close
- GBP 2,696.25
- Volume
- 0
- Average Volume (3M)
- 2,468
- AUM
- 99.20M
- NAV
- 26.84
- Expense Ratio
- 0.20%
- Holdings Count
- 66
- Beta
- 1.03
- Inception Date
- Oct 21, 2013
- Last Dividend Ex-Date
- Aug 13, 2026
- Dividend Yield
- (2.96%)
- Shares Outstanding
- 2,364,395
- Standard Deviation
- N/A
ETF Overview
UBS ETF MSCI UK Shs -A- Distribution
The UBS ETF MSCI UK Shs -A- Distribution, with the ticker GB:UC63, is a compelling investment vehicle designed for those looking to capture the broad spectrum of the UK equity market. This ETF is categorized under Size and Style, with a distinct focus on Total Market, making it an ideal choice for investors seeking comprehensive exposure to the UK's financial landscape. By tracking the MSCI UK Index, it encompasses a wide array of companies across various sectors, offering a diversified approach to investing in the UK's economic prowess. Known for its broad-based niche, this ETF provides access to both established giants and emerging leaders within the market, ensuring a balanced investment strategy. The distribution class of the fund further enhances its appeal by offering regular income to investors, making it not only a strategic growth tool but also a source of steady returns. Whether you're a seasoned investor or new to the UK market, the UBS ETF MSCI UK Shs -A- Distribution stands out as a robust option for those aiming to harness the full potential of the UK's dynamic market environment.
- Asset Class
- Equity
- Region
- Europe
- Issuer
- UBS
- Index Tracked
- MSCI United Kingdom
- Ticker Symbol
- GB:UC63
GB:UC63 ETF News


AstraZeneca plc ($GB:AZN) announced an update on their ongoing clinical study. Study Overview: AstraZeneca’s GRACE-DE study, officially titled “Prospective, Observational, Multicenter, and Multicohort Study of Patients With Gastric Cancer Initiating




GB:UC63 ETF FAQ
What was GB:UC63’s price range in the past 12 months?
What is the AUM of GB:UC63?
Is GB:UC63 overvalued?
Does GB:UC63 pay dividends?
How many shares outstanding does GB:UC63 have?
GB:UC63 ETF Smart Score
Top 10 Holdings
| Name | Weight % |
|---|---|
| HSBAHsbc Holdings Plc (UK) | 9.65% |
| SHELShell plc (UK) | 9.05% |
| AZNAstraZeneca plc | 8.88% |
| RRRolls-Royce Holdings | 4.71% |
| ULVRUnilever Plc (UK) | 4.54% |
| BATSBritish American Tobacco (UK) | 3.85% |
| BPBP p.l.c. | 3.79% |
| GSKGlaxoSmithKline plc (UK) | 3.22% |
| RIORio Tinto (LSE:RIO) | 2.75% |
| NGNational Grid (Uk) | 2.66% |
| Total | 53.09% |









